Integral Derivatives’s Merck MRK Stock Holding History

Integral Derivatives’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$820K	Buy	+15,785	New	+$853K	0.02%	289
2017 Q4	–	Sell	-8,398	Closed	-$466K	–	1232
2017 Q3	$513K	Sell	8,398 -9,416	-53%	-$571K	0.01%	725
2017 Q2	$1.09M	Sell	17,814 -13,101	-42%	-$797K	0.02%	458
2017 Q1	$1.87M	Buy	30,915 +17,980	+139%	+$1.09M	0.03%	330
2016 Q4	$727K	Sell	12,935 -18,487	-59%	-$1.08M	0.01%	606
2016 Q3	$1.87M	Buy	31,422 +10,585	+51%	+$619K	0.04%	281
2016 Q2	$1.15M	Buy	20,837 +7,860	+61%	+$418K	0.03%	375
2016 Q1	$655K	Buy	+12,977	New	+$636K	0.02%	464
2015 Q3	–	Sell	-4,500	Closed	-$239K	–	1207
2015 Q2	$244K	Buy	+4,500	New	+$252K	0.01%	925
2014 Q4	–	Sell	-43,727	Closed	-$2.44M	–	1487
2014 Q3	$2.47M	Sell	43,727 -4,970	-10%	-$279K	0.04%	385
2014 Q2	$2.69M	Buy	48,697 +34,023	+232%	+$1.86M	0.05%	322
2014 Q1	$795K	Buy	+14,674	New	+$760K	0.02%	732

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's MRK Position: Q1 2018 in Review

Integral Derivatives opened a new position in Merck (MRK) in Q1 2018: 15,785 shares worth $820K. The stake represents 0.02% of the portfolio and ranks #289 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in MRK as recently as Q3 2017.

Integral Derivatives first reported a position in MRK in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.69M in Q2 2014. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Integral Derivatives held 15,785 shares of Merck worth $820K as of Q1 2018.
Merck was a new Integral Derivatives position in Q1 2018.
Merck made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #289 holding.
Integral Derivatives first reported a position in Merck in Q1 2014 and has held it in 12 quarters since.
Integral Derivatives's Merck position peaked at $2.69M in Q2 2014.
1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.